- Patient with NSCLC and brain metastases and positive reassortment ALK treated with alectinib - case report2020 | Publication without faculty affiliation
- Role of alectinib in the treatment of advanced non-small cell lung cancer2020 | Third Faculty of Medicine
- Alectinib2017 | Third Faculty of Medicine
- Crizotinib - Still "gold standard" for patients with pulmonary adenocarcinoma with ALK translocation?2017 | Faculty of Medicine in Pilsen
- Two years longer and peaceful life thanks to alectinib2022 | Third Faculty of Medicine, Central Library of Charles University
- Treatment of ALK positive non-small cell lung cancer2021 | First Faculty of Medicine
- Alecensa - a new hope for patients with ALK positive non-small cell lung cancer2018 | Second Faculty of Medicine
- Alectinib v první linii léčby metastatického NSCLC s pozitivní přestavbou genu ALK2019 | Second Faculty of Medicine
- Long time successful treatment of a young patient suffering from advanced ALK rearreged lung adenocarcinoma2018 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Non-small cell lung cancer with ALK and R0S1 genes rearregement2018 | Faculty of Medicine in Pilsen
- Optimal procedure in treatments of advanced ALK-positive and ROS1-positive non-small cell lung cancers2019 | Third Faculty of Medicine
- Interactions of Alectinib with Human ATP-Binding Cassette Drug Efflux Transporters and Cytochrome P450 Biotransformation Enzymes: Effect on Pharmacokinetic Multidrug Resistance2019 | Faculty of Pharmacy in Hradec Králové
- Case report of a patient with metastatic non-small cell lung cancer with positive ALK gene rearrangement treated in the first line with alectini2020 | Publication without faculty affiliation
- Rare case of choroidal metastasis in ALK-positive NSCLC that responds to crizotinib2019 | First Faculty of Medicine
- ALK-driven non-small cell lung cancer: Prevention, prophylaxis, and treatment of brain metastases2021 | Faculty of Medicine in Pilsen
- When not even four ALK inhibitors are enough2020 | Faculty of Medicine in Pilsen
- Current procedures and news in the treatment of lung cancer2021 | First Faculty of Medicine
- Lorlatinib in the treatment of non‑small cell lung cancer2020 | Publication without faculty affiliation
- Multidisciplinary approach to the lung adenocarcinoma treatment in a young patient2019 | Third Faculty of Medicine
- Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma2023 | Faculty of Medicine in Pilsen